International Psoriasis Council

Advancing Knowledge. Improving Care.

Banner with ESDR, IEC, and IPC logos on the left, highlighting eczema research at the 55th Annual ESDR Meeting Heidelberg, Germany. A photo on the right shows Heidelberg with the Neckar River and historic stone bridge.

IEC-IPC Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum

55TH ANNUAL EUROPEAN SOCIETY FOR INVESTIGATIVE DERMATOLOGICAL RESEARCH MEETING (ESDR) | HEIDELBERG, GERMANY

September 9, 2026
 | 08:00 – 12:00 CEST
Location: Heidelberg, Germany

Add this event to your calendar

Apple Google Outlook Outlook.com Office 365 Yahoo

The IEC–IPC Eczema and Psoriasis Research Incubator is a pre-congress, interactive forum designed to catalyze cross-disciplinary collaboration and accelerate innovation across inflammatory skin diseases. Featuring keynote presentations from global thought leaders, the program moves from cutting-edge insights into disease mechanisms and precision stratification to data-driven, translational approaches that inform real-world practice. Participants will engage in rapid-fire early-career presentations and structured small-group “Challenge Labs” focused on priority research themes, with the goal of identifying actionable gaps and shaping collaborative project concepts. This highly interactive format emphasizes practical outcomes, new partnerships, and sustained engagement beyond the session. Early-career investigators are strongly encouraged to apply.

Agenda

Registration and Breakfast

Welcome & Framing Remarks

KEYNOTE: From Mechanism to Precision: Defining Disease Endotypes
Johann Gudjonsson, MD, PhD, United States

KEYNOTE: From Data to Impact: Translating Evidence into Practice
Satveer Mahil, PhD, FRCP, United Kingdom

Lightning Talks: Early-Career Investigator Spotlights

BREAK

Challenge Labs: Small Group Innovation Sessions

  • Shared comorbidities
  • Mechanisms of disease
  • Endotypes
  • Treatment stratification
  • Precision medicine
  • Paradoxical cases
  • Global challenges

Report-Outs & Expert Commentary Panel

Closing Reflections & Next Steps

Program Chairs

Sara Brown, MBChB, MD

University of Edinburgh

Edinburgh, Scotland, United Kingdom

Bio

Johann Gudjonsson, MD, PhD

University of Michigan, Department of Dermatology

Ann Arbor, Michigan, United States

IPC Board Member

Bio

Fernando Valenzuela, MD

University of Chile, University of the Andes

Santiago, Chile

IPC Councilor

Bio

Nicole Ward, PhD

Vanderbilt University Medical Center

Nashville, Tennessee, United States

IPC Councilor

Bio

Program Faculty

John Edmund Armourer Common, PhD

Newcastle University

Newcastle upon Tyne, United Kingdom

Bio

Paola Di Meglio, PhD

King’s College London

London, United Kingdom

IPC Councilor

Bio

Christopher Griffiths, OBE, MD, FMedSci

University of Manchester and King’s College London

London, United Kingdom

IPC Honorary Founder

Bio

Claus Johansen, MSc, PhD, DMSc

Aarhus University Hospital

Aarhus, Denmark

IPC Councilor

Bio

Anna López Ferrer, MD, PhD

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Councilor

Bio

Satveer Mahil, PhD, FRCP

St John’s Institute of Dermatology

London, United Kingdom

IPC Councilor

Bio

Andreas Pinter, MD, PhD

University Hospital Frankfurt

Frankfurt, Germany

IPC Councilor

Bio

Luis Santamaria-Babí, PhD

University of Barcelona

Barcelona, Spain

Bio

This program is supported in part by

A line drawing of a lion walking above the word LEO with a horizontal line underneath, and LEO FOUNDATION written in large capital letters below, symbolizing strength and dedication to advancing eczema research.

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026